NCT06787755Completed
Persistent COVID-19 Symptoms in Minia
Persistent COVID-19 Symptoms in Minia, Upper Egypt: an Observational Cross-sectional Study
Source: ClinicalTrials.gov · Last updated 22 Jan 2025
Brief summary (registry, in English)
Objective This study aims to identify the nature and prevalence of persistent symptoms in patients discharged from Minya University hospitals in Egypt after recovery from COVID-19, the severity of these symptoms, and the possible risk factors associated with them.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 189 (actual)
- First submitted
- 19 Jan 2025
- Start date
- 10 Mar 2021
- Primary completion date
- 10 Sept 2023
- Lead sponsor
- Fayoum University
- NCT number
- NCT06787755
What you commit to
- Study type: Observational
- Participants enrolled: 189
- From 10 Mar 2021 to the primary completion date, 10 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- \- Inclusion criteria Patients were included in this study if they tested positive for COVID-19 at the time of their illness (positive COVID-19 polymerase chain reaction \[PCR\] test) or if laboratory, clinical, and radiological criteria suggested the infection with COVID-19, and the severity of their symptoms ranged from asymptomatic to severe. Both hospitalized and non-hospitalized patients were included.
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Marwa Coordinator of this site? Confirm its status | Al Fayyum | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.